Tilray Brands (TLRY) | Stock Overview & Key Data
Tilray Brands Performance Comparison
Stock Range
Today's Range
Low: $1.08
High: $1.15
on September 12, 2025
52 Week Range
Low: $0.35
High: $1.88
on June 23, 2025
on September 17, 2024
All-Time High: $300.00 on September 17, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.2B
EPS
-2.46
P/E Ratio (TTM)
-0.46
Forward P/E
-16.00
P/B Ratio
0.78
PEG Ratio
-16.00
Div. Yield
N/A
ROE
-88.44%
Beta
2.078
Debt to Equity
22.07
Financial Highlights
Profitability
Gross Margin
30.12%
Operating Margin
-6.38%
Profit Margin
-266.25%
Returns and Earnings
Return on Assets (TTM)
-2.13%
Return on Equity (TTM)
-88.44%
EBITDA
$19.4M
Net Income (TTM)
$-2.2B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.78
Quarterly Revenue Growth (YoY)
-2.30%
Quarterly Earnings Growth (YoY)
-2.33%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Tilray Brands TLRY | 1.23B Small-cap | -5.88% | 17.89% | 166.67% | 75.00% | -23.29% | -35.63% | -64.89% | -79.03% |
| Zoetis ZTS | 65.30B Large-cap | -1.97% | 4.93% | -9.07% | -8.19% | -5.71% | -18.98% | -6.69% | -3.32% |
| Haleon Plc - ADR HLN | 45.42B Large-cap | 0.10% | 2.40% | -10.90% | -3.73% | 3.92% | -6.66% | 66.84% | 32.39% |
| BioCryst BCRX | 1.66B Small-cap | -4.35% | -5.27% | -23.94% | 2.59% | 1.02% | 0.00% | -39.77% | 97.51% |
| Phibro Animal Health PAHC | 1.61B Small-cap | 0.43% | 33.49% | 61.65% | 79.60% | 91.12% | 80.17% | 173.81% | 120.60% |
| BGM BGM | 1.48B Small-cap | 1.79% | -0.81% | -52.72% | -26.79% | -17.45% | 13.89% | 20.98% | -83.13% |
Ownership & Short Interest
Insider Ownership
0.80%
Institutional Ownership
9.88%
Shares Short
162M
Short Ratio
1.94
Short % of Shares Outstanding
14.82%
Average 10-Day Volume
48M
Average 90-Day Volume
77M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TLRY's 52-week high and low?
- In the last 52 weeks, Tilray Brands reached a high of $1.88 (on September 17, 2024) and a low of $0.35 (on June 23, 2025).
- What is the market cap and P/E ratio for TLRY?
- Curious about Tilray Brands's size and valuation? Its market capitalization stands at 1.23B. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.46, and the forward P/E (looking ahead) is -16.00.
- Does TLRY pay dividends? If so, what's the yield?
- As for dividends, Tilray Brands isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Tilray Brands's main competitors or similar companies to consider before investing?
When looking at Tilray Brands, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.30B Healthcare Drug Manufacturers - Specialty & Generic -18.98% -6.69% Haleon Plc - ADR
HLN45.42B Healthcare Drug Manufacturers - Specialty & Generic -6.66% 66.84% BioCryst
BCRX1.66B Healthcare Drug Manufacturers - Specialty & Generic 0.00% -39.77% Phibro Animal Health
PAHC1.61B Healthcare Drug Manufacturers - Specialty & Generic 80.17% 173.81% BGM
BGM1.48B Healthcare Drug Manufacturers - Specialty & Generic 13.89% 20.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Tilray Brands Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Tilray Brands's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -88.44%, the Debt to Equity ratio from the most recent quarter is 22.07, and its Gross Profit Margin stands at 30.12%.
- What is the recent revenue and earnings growth for TLRY?
- Looking at Tilray Brands's growth, its revenue over the trailing twelve months (TTM) was $821M. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.30%, and quarterly earnings saw a YoY growth of -2.33%.
- How much of TLRY stock is held by insiders and institutions?
- Wondering who owns Tilray Brands stock? Company insiders (like executives and directors) hold about 0.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.